Hospital News and Research

RSS

WaferGen Biosystems first-quarter revenues increase to $389,785

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genome analysis systems, today reported performance results for the first quarter ended March 31, 2010.

17 May 2010

Health law's affect on ERs, doctors' panel, young adults examined

Officials and stakeholders are examining the new health reform law for changes that the reform will mean for their organizations and industries.

17 May 2010

Hospitals to get more bargaining clout for medical devices

The Wall Street Journal: "Hospitals lack leverage when negotiating prices for high-cost implants like defibrillators and replacement hips because individual doctors, rather than hospitals, typically select the products they use in their patients. Since these doctors often aren't hospital employees, they have little incentive to bargain-hunt.

17 May 2010

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the first patient has been treated in the company's U.S. Phase 2 catheter-based clinical trial to treat dilated cardiomyopathy (DCM). Treatment was performed by interventional cardiologist Timothy D. Henry, M.D., FACC, at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, MN.

17 May 2010

Communication Intelligence first-quarter total revenue decreases to $207,000

Communication Intelligence Corporation, a leading supplier of electronic signature solutions for business process automation in the financial industry and the recognized leader in biometric signature verification, announced today its financial results for the first quarter ended March 31, 2010.

17 May 2010

FDA approves ROXRO PHARMA's SPRIX Nasal Spray

ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.

17 May 2010

Hemispherx Biopharma to conduct study of Ampligen antiviral in China

As part of its expanding international program Hemispherx Biopharma, Inc., announced an agreement with Fountain Medical Development Ltd., a leading Chinese clinical research organization (CRO) to prepare, file and gain approval from the authorities in China to conduct a study of Ampligen, an investigational therapeutic.

17 May 2010

ARCA biopharma announces SPA agreement with FDA for bucindolol clinical trial

ARCA biopharma, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a clinical trial to assess the safety and efficacy of bucindolol in approximately 3,200 patients with chronic heart failure who have the genotype that appears to respond most favorably to bucindolol. Bucindolol is the Company's investigational, pharmacologically unique, beta-blocker and mild vasodilator.

17 May 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Tranzyme Pharma today announced that Philippa Charlton, MD, Tranzyme's Medical Director, and her colleagues G. Bochicchio, J.C. Pezullo, G. Kosutic, and A. Senagore, will present a poster entitled "The Prokinetic Agent TZP-101 (a Ghrelin Agonist) Accelerates GI Recovery in Partial Colectomy Patients Independently of Total Opioid Use and Type of Surgery" at the upcoming 2010 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons (ASCRS; Minneapolis, May 15-19).

17 May 2010

Most recurrences of HCC occur early after initial diagnosis and treatment: Research article

Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.

17 May 2010

The Neuropathy Association joins with the Empire State Building to recognize National Neuropathy Week

For National Neuropathy Week, May 17-21, The Neuropathy Association will join with the Empire State Building to raise neuropathy awareness, recognize National Neuropathy Week, and commemorate the Association's 15th Anniversary.

17 May 2010

UHS reaches definitive agreement to acquire PSI for $2.0 billion

Universal Health Services, Inc. and Psychiatric Solutions, Inc. announced today that they have reached a definitive agreement whereby UHS will acquire PSI for a price of $33.75 per share in cash, or approximately $2.0 billion.

17 May 2010

Blood-flow fMRI to be used to study brain-wide impact of neural circuitry changes

Like a motorist who knows that the "check engine" light indicates something important but ill-defined is happening, neuroscientists have relied heavily on an incompletely understood technology called functional magnetic resonance imaging to show them what the brain is doing when people respond to different stimuli.

17 May 2010

New data from MVP trial on ICDs shows health care use burden

Medtronic, Inc. today released new data from the MVP trial that implantable defibrillator patients receiving anti-tachycardia pacing were less likely to have health care utilization after treatment as compared to those receiving shock therapy.

17 May 2010

HIV patients falsely diagnosed for TB have higher rates of mortality: Study

HIV-infected patients who are falsely diagnosed as having tuberculosis have higher rates of mortality than those who are correctly diagnosed with the disease, according to a study conducted by researchers at University of California-San Francisco and Makerere University-Kampala.

17 May 2010

Long-term, regular use of vitamin E in women may help decrease risk of COPD: Study

Long-term, regular use of vitamin E in women 45 years of age and older may help decrease the risk of chronic obstructive pulmonary disease by about 10 percent in both smokers and non-smokers, according to a study conducted by researchers at Cornell University and Brigham and Women's Hospital.

17 May 2010

Study describes association between childhood asthma and risk of developing adult COPD

Children with severe asthma have more than 30 times the risk of developing adult chronic obstructive lung disease as adults compared to children without asthma, according to a prospective longitudinal cohort study from the Royal Children's Hospital in Melbourne.

17 May 2010

Anti-abortion groups use health law in efforts to restrict insurance coverage

Abortion opponents fought passage of President Barack Obama's health care overhaul to the bitter end, and now that it's the law, they're using it to limit coverage by private insurers. An obscure part of the law allows states to restrict abortion coverage by private plans operating in new insurance markets.

17 May 2010

3SBio's first-quarter 2010 total net revenues up 40.5%

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2010.

17 May 2010

Indigenous Australians at higher risk of diseases: studies

Central Australia ranks first in incidences of pneumonia among children with alarming figures like 78.4 cases per 1,000 children annually. This is much higher than even South Africa, Uruguay, Gambia, Fiji or Pakistan.

16 May 2010